N. D. Reddy

Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo.

S. Narayanan, K. Chandrasekhar, N. Kulkarni, 2015, European journal of pharmacology.

Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation

U. Krishnan, S. Narayanan, G. Vijaykanth, 2015, Archives of pharmacal research.

6b,11b-Dihydroxy-6b,11b-dihydro-7H-indeno[1,2-b]naphtho[2,1-d]furan-7-one (DHFO), a small molecule targeting NF-κB, demonstrates therapeutic potential in immunopathogenic chronic inflammatory conditions.

M. Unnikrishnan, G. Mathew, N. D. Reddy, 2013, International immunopharmacology.

Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenografts

S. Narayanan, G. Vijaykanth, K. Karthikeyan, 2017, Anti-cancer drugs.

In vivo radioprotection studies of 3,3'-diselenodipropionic acid, a selenocystine derivative.

P. Bag, K. Priyadarsini, A. Kunwar, 2010, Free radical biology & medicine.

Investigating the potential of tetrahydropyridinyl chalcones as useful agents against breast carcinoma: An in vitro and in vivo study

J. Venkata Rao, B. Jayashree, S. Nigam, 2018, Research on Chemical Intermediates.

Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation

U. Krishnan, S. Narayanan, G. Vijaykanth, 2014, Archives of Pharmacal Research.